Somatoform disorders in the family doctor's practice.
DOI:
https://doi.org/10.26641/2307-0404.2013.4.20036Keywords:
somatoformic disorders, vegetative dysfunction, metabolic therapy, anxiolyticsAbstract
In the second part of the article devoted to the problem of somatoform disorders, hypochondriacal disorder, somatoform dysfunction of the autonomic nervous system and sustained somatoform pain disorder are reviewed. Vegetative dysfunction can occur as a separate disorder and may be accompanied by a variety of somatic diseases which distorts and exacerbates their symptoms. In patients with arterial hypertension the authors revealed the presence of vegetative dysfunction in 90%, which correlated with an anxiety disorder by the HADS scale. In clinical practice there are permanent and paroxysmal vegetative dysfunctions. The last ones are manifested by vegetative crises with predominance of sympathoadrenal or vagus-insular symptoms. Approaches to treatment of vegatative disorders and drugs of various pharmacological groups are also discussed in the article. Based on the analysis of published data it is shown that non-benzodiazepine anxiolytic drug Adaptol in single or combined therapy in patients with somatoform disorders promotes fast and effective reduction of mental, emotional and vegetative components of the disease, without limiting work performance and activity of patients.References
Баранцевич Е.Р. Клинико-нейрофизиоло¬гичес¬кое исследование эффективности адаптола при дис¬циркуляторной энцефалопатии / Е.Р. Баранцевич, О.В. По¬сохина // Журнал неврологии и психиатрии. – 2011. – № 9.
Бурчинський С.Г. Нові аспекти фармако¬тера¬пії психосоматичної патології / С.Г. Бурчинський // Лі¬ки. – 2004. – № 5-6. – С. 28-32.
Громов Л.А. «Типичные « и «атипичные» тран¬к¬вилизаторы / Л.А. Громов, Е.Т. Дудко // Вестник фармакологии и фармации. – 2003. – № 10.
Депрессивная симптоматика ухудшает прог¬ноз у больных артериальной гипертонией и ишеми¬ческой болезнью сердца: первые результаты проспек¬тивного этапа российского многоцентрового иссле¬дования КООРДИНАТА / Е.И. Чазов, Р.Г. Оганов, Г.В. По¬госова [и др.] // Кардиология. - 2007. - № 10. -С. 24-30.
Клинико-нейрофизиологическое исследование эффективности препарата адаптол при лечении син¬д¬рома эмоционального выгорания / Л.С. Чутко, С.Ю. Су¬руш¬кина [и др.] // Журнал неврологии и психи¬атрии им. С.С. Корсакова. – 2010. – 10.
Клинико-психологическая характеристика пациентов с кардиофобическим синдромом / О.В. Сте¬р¬лин, Н.Л. Фролова, Ю.И. Сидорова [и др.] // Кардио¬логия и сердечно-сосудистая хирургия. – 2011. – T. 4, № 5. – С. 34-36.
Коваленко I.В. Психосоматичні розлади: діаг¬нос¬тика та лікування / I.В. Коваленко. – Вінниця: Кон¬соль, 2005. – 32с.
Литвиненко Н.В. Влияние препарата “вазонат” на умеренные когнитивные расстройства при хро¬нических нарушениях мозгового кровообращения / Н.В. Лит¬ви¬ненко, И.И. Дельва, М.Ю. Дельва // Укр. вісник психо¬неврології. – 2011. – Т. 19, вип. 1 (66). –– С. 22-25.
Морозова О.Г. Коррекция вегетативных и тре¬вожных нарушений в практике врача-интерниста / О.Г. Морозова // Новости медицины и фармации. – 2007. – Вып. 215.
Неврология для врачей общей практики / А.М. Вейн, Т.Г. Вознесенская, О.В. Воробьева [и др.]. – М.: Эйдос Медиа, 2001. – 504 с.
Погорєлов О.В. Оптимізація ноотропної тера¬пії в постінсультному періоді. Вазонат / О.В. Пого¬рє¬лов // Укр. вісник психоневрології. – 2010. – Т. 18, вип. 4 (65).
Погосова Г.В. Психоэмоциональные рас¬строй¬с¬т¬ва при сердечно-сосудистых заболеваниях: терапев¬тические аспекты / Г.В. Погосова // Consilium me¬dicum. – 2006. – Т. 8, № 5. – С. 54-57.
Подкорытов В.С. Соматоформные рас¬стройст¬ва / В.С. Подкорытов, О.И. Серикова // Medicus Ami¬cus. – 2002, №1.
Психокардиология / А.Б. Смулевич, А.Л. Сыркин, М.Ю. Дробижев, С.В. Иванов. – М., 2005. – 778 с.
Смулевич А.Б. Депрессии в общемедицинской практике / А.Б. Смулевич. – М., 2000. – 160 с.
Смулевич А.Б. Депрессии при соматических и психических заболеваниях / А.Б. Смулевич. – М.: Мед. информ. агенство, 2003. – 432 с.
Турсунова К.Б., Применение адаптола у па¬циен¬тов с хронической цервикогенной головной болью / К.Б. Турсунова, Л.С. Чутко // Журнал невро¬ло¬гии и психиатрии, 2011. – № 67.
Успенский Ю.П. Тревожные расстройства и их коррекция в гастроэнтерологической практике / Ю.П. Успенский, Е.В. Балукова // Consilium Medicum. – 2008. – Т. 10, № 8.
Эффективность и целесообразность использо¬вания вазоната в комплексной терапии ишемической болезни сердца / Е.П. Смуглов, Н.А. Шадчнева, В.Н. Зо¬рин [и др.] // Медичні перспективи. – 2011. – Т. XVI, № 3.
Burnout syndrome in critical care nursing staff / M.C. Poncet, P. Toullic, L. Papazian [et al.] // Am. J. Res¬pir. Crit. Care Med. – 2007. – Vol. 175, N 7. – P. 698-704.
European Guidelines on cardiovascular disease prevention in clinical practice // The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clini¬cal Practice (constituted by representatives of nine societies and by invited experts). – 2012.
Fukunaga M. Concept of functional somatic syn¬dromes / M. Fukunaga, Y. Nakai // Nippon Rinsho. – 2009. – Vol. 67, N 9. P. 1647–1651.
Functional illness in primary care: dysfunction ver¬sus disease / N. Williams, C. Wilkinson, N. Stott, D.B. Menkes // BMC Fam Pract. – 2008. – N 9. – P. 30–41.
Katon W. Panig disorder and somatization: Re¬view of 55 cases / W. Katon // Am. J. Med. – 1984. – Vol. 77. – P. 101-106.
Maslach C. The Maslach Burn-Out Inventory Man¬nual. – 2nd ed. / C. Maslach, S.E. Jackson. – Palo Alto. CA: Consulting Psychologist Press, 1986.
Mokina T.V. Use of Adaptol in the Treatment of Chronic Fatigue Syndrome in Patients with Chronic Cerebral Ischemia / T.V. Mokina, E.A. Antipenko, A.V. Gus¬tov // Neuroscience Behavioral Physiology. – 2010. – Vol. 40, Issue 7. – P. 757-759.
Salawu F.K. Overview of somatization–diagnosis and management / F.K. Salawu, M.A. Wakil, A. Dan¬bu¬ram // Niger. J. Med. – 2009. – Vol. 18, N 4. – P. 349–353.
Barantsevich ER , Posokhina OV. Clinical and neurophysiological study of the effectiveness of ADAPTOL at dyscirculatory encephalopathy. Zhurn. Nev¬rologii i psikhiatrii. 2011;111(9):68-72.
Burchins'kiy SG. New aspects in drug therapy of psychosomatic disorders. Lіki.2004;5-6:28-32.
Gromov LA, Dudka ET. "Typical" and "atypical" tranquilizers. Vestnik farmakologii i farmatsii. 2003;10:12-17.
Chazov EI, Oganov RG, Pogosova GV. Dep¬res¬sive symptoms worse prognosis in patients with hyper¬tension and coronary heart disease: first results of Russian prospective multicenter study COORDINATE. Kardiol. 2007;10:24-30.
Chutko LS, Surushkina SYu et al. Clinical and neurophysiological study of the efficacy of the drug Adap¬tol in the treatment of emotional burnout. Zhurn. nevrologii i psikhiatrii im. S.S. Korsakova. 2010;10.
Sterlin OV, Frolova NL, Sidorova YuI, Shcheg¬lova LV, Chutko LS. Clinical and psychological cha¬racteristics of patients with cardiophobic syndrome. Zhurn. Kardiologiya i serdechno-sosudistaya khirurgiya. 2011;5(4):34-36.
Kovalenko IV. Psychosomatic disorders: diagnos¬tics and treatment. Vіnnitsya: Konsol'. 2005;32.
Litvinenko NV, Del'va II, Del'va MYu. The in¬fluence of the drug "Vazonat" on mild cognitive im¬pairment in chronic cerebrovascular disorders. Ukraїn¬s'kiy vіsnik psikhonevrologії. 2011;19.1(66):22-25.
Morozova OG. Correction of vegetative and an¬xiety disorders in the practice of internist. Novosti medit¬siny i farmatsii. 2007;215.
Vein AM. Neurology for General Practitioners. Eidos Media. 2001;504.
Pogorjelov OV. Optimization of neuroprotective therapy in post-stroke period. VAZONAT. Zhurn. Uk¬rai'ns'kyj visnyk psyhonevrologii'. 2010;4(65):28-31.
Pogosova GV. Psycho-emotional disorders in car¬dio¬vascular diseases: the therapeutic aspects. Consilium medicum. 2006;8(5):54-57.
Podkorytov VS, Serikova OI. Somatoform disor¬ders. Medicus Amicus. 2002;1.
Smulevich AB, Syrkin AL, Drobizhev MYu, Iva¬nov SV. Psychocardiology. – Moscow. 2005;778.
Smulevich AB. Depression in general practice. Moscow. 2000;160.
Smulevich AB. Depression with somatic and psy¬chiatric diseases. M.: Med. inform. Agenstvo. 2003;432.
Tursunova KB, Chutko LS. Application of ADAPTOL in patients with chronic cervicogenic headache. Zhurnal nevrologii i psikhiatrii. 2011;111(6):68-69.
Uspenskiy YuP, Balukova EV. Anxiety disorders and their correction in gastroenterological practice. Con¬silium Medicum. 2008;8(10).
Smuglov EP, Shadchneva NA, Zorin VN, Kuz¬netsov NS, Sakhaltuev AD, Plastun MYu. The efficacy and feasibility of Vazonat in the treatment of coronary heart disease. Zhurn. Medichnі perspektivi. 2011;3(XVI):64-72.
Poncet MC, Toullic P, Papazian L, Kentish-Barnes N, Timsit JF, Rochard F. Burnout syndrome in critical care nursing staff. Am J Respir Crit Care Med. 2007;175(7):698-704.
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
Fukunaga M, Nakai Y. Concept of functional somatic syndromes.//Nippon Rinsho. 2009;67(9):1647–51.
Williams N, Wilkinson C, Stott N, Menkes DB. Functional illness in primary care: dysfunction versus disease. BMC Fam Pract. 2008;9:30–41.
Katon W. Panig disorder and somatization: Re¬view of 55 cases. Am J Med 1984;77:101-6.
Maslach C, Jackson SE. The Maslach Burn-Out Inventory Mannual, 2nd ed. Palo Alto. CA: Consulting Psy¬chologist Press 1986.
Mokina TV, Antipenko EA., Gustov AV. Use of Adaptol in the Treatment of Chronic Fatigue Syndrome in Patients with Chronic Cerebral Ischemia, Neuroscience Behavioral Physiology. 2010:40(7):757-59.
Salawu FK, Wakil MA, Danburam A. Overview of somatization–diagnosis and management. Niger J Med. 2009;18(4):349–53.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medical Perspectives
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
